Applying genetic discoveries to psychiatric care

In an ongoing project we are testing if knowing copy number variant(CNV) carrier status can influence schizophrenia care. Copy number variations are structural DNA variations such as deletions and duplications—known to be pathogenic, increasing risk not just for schizophrenia but other neuropsychiatric conditions. After testing, positive results are relayed to the clinician/treatment team to assess clinical value i.e. if this knowledge improves clinical care.